The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Retinoic acid-loaded NFL-lipid nanocapsules promote oligodendrogenesis in focal white matter lesion
Abstract
Neural stem cells (NSC) are located in restricted areas of the central nervous system where they self-renew or differentiate into neurons, astrocytes or oligodendrocytes. The stimulation of endogenous NSC differentiation is one of the most promising therapeutic approaches to restore neurological function in patients affected by neurodegenerative diseases. Endogenous NSC of the subventricular zone (SVZ) can be selectively targeted by lipid nanocapsules (LNC) coated with the peptide NFLTBS.40-63 (NFL-LNC) after intra-lateral ventricular injection in the brain. NFL-LNC can potentially deliver active compounds to SVZ-NSC and thus promote their differentiation to treat neurodegenerative diseases. The aim of this work was to induce endogenous NSC differentiation by specifically delivering retinoic acid (RA) to SVZ-NSC via NFL-LNC. RA was successfully encapsulated into NFL-LNC and RA-NFL-LNC were incubated with primary rat SVZ-NSC. In vitro, RA-NFL-LNC decreased the number of nestin + (NSC marker) cells and neurospheres compared to controls and increased the number of GalC + (oligodendrocytic marker) cells. Then, RA-NFL-LNC were injected in the right lateral ventricle of a lysolecithin-induced rat focal white matter lesion model to evaluate their impact on oligodendrocyte repopulation and remyelination. RA-NFL-LNC significantly increased the percentage of mature oligodendrocytes, stimulating oligodendrogenesis, nearly to the pre-lesion levels. Thus, RA-NFL-LNC represent a promising…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“If this necroptotic wave is dysregulated, microglia act as a potential source of chronic inflammation (Carradori et al. 2020).”
From MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis (2025) · cites this paper as Carradori et al. 2020
In the citing paper
“There is a proposed mechanism for this failure in demyelination that first pro-inflammatory microglia undergo necroptosis then occur repopulation of microglia with shift to a neuroprotective state.”
From MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis (2025) · cites this paper as Carradori et al. 2020
Citations
Cites
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
Self-citationGlycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Fünfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Möbius, W., et al. (2012) · Nature · doi:10.1038/nature11007 · Cited by 1,523
Central nervous system regeneration is driven by microglia necroptosis and repopulation
Lloyd, A. F., Davies, C. L., Holloway, R. K., Labrak, Y., Ireland, G., Carradori, D., Dillenburg, A., Borger, E., Soong, D., Richardson, J. C., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0418-z · Cited by 316
Self-citationZhang, Q., Zhu, W., Xu, F., Dai, X., Shi, L., Cai, W., Mu, H., Hitchens, T. K., Foley, L. M., Liu, X., et al. (2019) · PLOS Biology · doi:10.1371/journal.pbio.3000330 · Cited by 160
Maki, T., Liang, A. C., Miyamoto, N., Lo, E. H., & Arai, K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00275 · Cited by 99
Research works printed but not linked: 56
- Vadakkan, 2016, Neurodegenerative disorders share common features of “loss of function” states of a proposed mechanism of nervous system functions, Biomed. Pharmacother., 83, 412, 10.1016/j.biopha.2016.06.042 · DOI
- Barnham, 2004, Neurodegenerative diseases and oxidative stress, Nat. Rev. Drug Discov., 3, 205, 10.1038/nrd1330 · DOI · Paper page
- Ettle, 2016, Oligodendroglia and myelin in neurodegenerative diseases: more than just bystanders?, Mol. Neurobiol., 53, 3046, 10.1007/s12035-015-9205-3 · DOI · Paper page
- Vishwakarma, 2014, Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: a review, J. Adv. Res., 5, 277, 10.1016/j.jare.2013.04.005 · DOI
- Murrell, 2013, Expansion of multipotent stem cells from the adult human brain, PLoS One, 8, e71334, 10.1371/journal.pone.0071334 · DOI
- Carradori, 2017, The therapeutic contribution of nanomedicine to treat neurodegenerative diseases via neural stem cell differentiation, Biomaterials, 123, 77, 10.1016/j.biomaterials.2017.01.032 · DOI
- Herberts, 2011, Risk factors in the development of stem cell therapy, J. Transl. Med., 9, 29, 10.1186/1479-5876-9-29 · DOI
- Simonson, 2015, The safety of human pluripotent stem cells in clinical treatment, Ann. Med., 47, 370, 10.3109/07853890.2015.1051579 · DOI
- Bocquet, 2009, Neurofilaments bind tubulin and modulate its polymerization, J. Neurosci., 29, 11043, 10.1523/JNEUROSCI.1924-09.2009 · DOI
- Lépinoux-Chambaud, 2016, The neurofilament‐derived peptide NFL‐TBS. 40‐63 targets neural stem cells and affects their properties, Stem cells Transl. Med., 5, 901, 10.5966/sctm.2015-0221 · DOI
- Fressinaud, 2014, Neurofilament-tubulin binding site peptide NFL-TBS.40-63 increases the differentiation of oligodendrocytes in vitro and partially prevents them from lysophosphatidyl choline toxiciy, J. Neurosci. Res., 92, 243, 10.1002/jnr.23308 · DOI
- Berges, 2012, Structure-function analysis of the glioma targeting NFL-TBS.40-63 peptide corresponding to the tubulin-binding site on the light neurofilament subunit, PLoS One, 7, e49436, 10.1371/journal.pone.0049436 · DOI
- Carradori, 2016, NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo, J. Control. Release, 238, 253, 10.1016/j.jconrel.2016.08.006 · DOI
- Huynh, 2009, Lipid nanocapsules: a new platform for nanomedicine, Int. J. Pharm., 379, 201, 10.1016/j.ijpharm.2009.04.026 · DOI
- Curtis, 2007, The effect of neurodegenerative diseases on the subventricular zone, Nat. Rev. Neurosci., 8, 712, 10.1038/nrn2216 · DOI
- Gonzalez-Perez, 2011, Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor, Brain Res. Rev., 67, 147, 10.1016/j.brainresrev.2011.01.001 · DOI
- Zhao, 2019, Combined use of bFGF/EGF and all-trans-retinoic acid cooperatively promotes neuronal differentiation and neurite outgrowth in neural stem cells, Neurosci. Lett., 690, 61, 10.1016/j.neulet.2018.10.002 · DOI
- Tan, 2015, Retinoic acid induced the differentiation of neural stem cells from embryonic spinal cord into functional neurons in vitro, Int. J. Clin. Exp. Pathol., 8, 8129
- Carradori, 2018, The origin of neural stem cells impacts their interactions with targeted-lipid nanocapsules: potential role of plasma membrane lipid composition and fluidity, J. Control. Release, 292, 248, 10.1016/j.jconrel.2018.11.005 · DOI
- Ito, 2014, Metabolic requirements for the maintenance of self-renewing stem cells, Nat. Rev. Mol. Cell Biol., 15, 243, 10.1038/nrm3772 · DOI · Paper page
- Maia, 2011, Controlling the neuronal differentiation of stem cells by the intracellular delivery of retinoic acid-loaded nanoparticles, ACS Nano, 5, 97, 10.1021/nn101724r · DOI · Paper page
- Xie, 2015, The effect of simvastatin treatment on proliferation and differentiation of neural stem cells after traumatic brain injury, Brain Res., 1602, 1, 10.1016/j.brainres.2014.03.021 · DOI
- Lamprecht, 2002, New lipid nanocapsules exhibit sustained release properties for amiodarone, J. Control. Release, 84, 59, 10.1016/S0168-3659(02)00258-4 · DOI
- Peltier, 2006, Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules, Pharm. Res., 23, 1243, 10.1007/s11095-006-0022-2 · DOI
- Resnier, 2017, Efficient ferrocifen anticancer drug and Bcl-2 gene therapy using lipid nanocapsules on human melanoma xenograft in mouse, Pharmacol. Res., 126, 54, 10.1016/j.phrs.2017.01.031 · DOI
- Lim, 2002, Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid, Int. J. Pharm.Stem Cells Transl. Med., 243, 135
- Castro, 2007, Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne, J. Microencapsul., 24, 395, 10.1080/02652040701288519 · DOI
- Li, 2011, All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells, J. Control. Release, 149, 281, 10.1016/j.jconrel.2010.10.019 · DOI · Paper page
- Lepinoux-Chambaud, 2016, The neurofilament-derived peptide NFL-TBS.40-63 targets neural stem cells and affects their properties, Stem Cells Transl.Med., 5, 901, 10.5966/sctm.2015-0221 · DOI
- Pastrana, 2011, Eyes wide open: a critical review of sphere-formation as an assay for stem cells, Cell Stem Cell, 8, 486, 10.1016/j.stem.2011.04.007 · DOI
- Johansson, 1999, Identification of a neural stem cell in the adult mammalian central nervous system, Cell, 96, 25, 10.1016/S0092-8674(00)80956-3 · DOI
- De Angelis, 2018, Short-term retinoic acid treatment sustains pluripotency and suppresses differentiation of human induced pluripotent stem cells, Cell Death Dis., 9, 6, 10.1038/s41419-017-0028-1 · DOI
- Wang, 2008, Retinoic acid maintains self-renewal of murine embryonic stem cells via a feedback mechanism, Differ.; Res. Biol. Divers., 76, 931
- Hsieh, 2016, A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting beta-catenin/LEF-1 signaling, Sci. Rep., 6, 19156, 10.1038/srep19156 · DOI
- Capurso, 2010, Development of a nanoparticulate formulation of retinoic acid that suppresses Th17 cells and upregulates regulatory T cells, Self Nonself, 1, 335, 10.4161/self.1.4.13946 · DOI
- Bianco, 2017, Rapid serum-free isolation of oligodendrocyte progenitor cells from adult rat spinal cord, Stem Cell Rev Rep, 13, 499, 10.1007/s12015-017-9742-4 · DOI
- Hattori, 2012, Effects of all-trans retinoic acid nanoparticles on corneal epithelial wound healing, Graefes Arch. Clin. Exp. Ophthalmol., 250, 557, 10.1007/s00417-011-1849-8 · DOI
- Pak, 2018, Combined therapy involving electroacupuncture and treadmill exercise attenuates demyelination in the corpus callosum by stimulating oligodendrogenesis in a rat model of neonatal hypoxia-ischemia, Exp. Neurol., 300, 222, 10.1016/j.expneurol.2017.11.014 · DOI
- Cullen, 2019, Low-intensity transcranial magnetic stimulation promotes the survival and maturation of newborn oligodendrocytes in the adult mouse brain, Glia, 67, 1462, 10.1002/glia.23620 · DOI
- Olmstead, 2018, Transcranial and pulsed focused ultrasound that activates brain can accelerate remyelination in a mouse model of multiple sclerosis, J. Ther. Ultrasound, 6, 11, 10.1186/s40349-018-0119-1 · DOI
- Li, 2017, Enhancing oligodendrocyte differentiation by transient transcription activation via DNA nanoparticle-mediated transfection, Acta Biomater., 54, 249, 10.1016/j.actbio.2017.03.032 · DOI
- Starossom, 2019, Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation, Nat. Commun., 10, 217, 10.1038/s41467-018-08140-7 · DOI
- Rittchen, 2015, Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF), Biomaterials, 56, 78, 10.1016/j.biomaterials.2015.03.044 · DOI
- Woodruff, 1999, Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study, Glia, 25, 216, 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L · DOI
- de Paula Faria, 2014, PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis, Mult. Scler., 20, 1443, 10.1177/1352458514526941 · DOI
- Roskams, 1998, Expression of neuron-specific beta-III tubulin during olfactory neurogenesis in the embryonic and adult rat, Neuroscience, 83, 191, 10.1016/S0306-4522(97)00344-8 · DOI
- Krencik, 2011, Specification of transplantable astroglial subtypes from human pluripotent stem cells, Nat. Biotechnol., 29, 528, 10.1038/nbt.1877 · DOI
- Godinho, 2013, Immunohistochemical, ultrastructural and functional analysis of axonal regeneration through peripheral nerve grafts containing Schwann cells expressing BDNF, CNTF or NT3, PLoS One, 8, e69987, 10.1371/journal.pone.0069987 · DOI
- Liedtke, 1996, GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination, Neuron, 17, 607, 10.1016/S0896-6273(00)80194-4 · DOI · Paper page
- Marei, 2018, Differentiation of human olfactory bulb-derived neural stem cells toward oligodendrocyte, J. Cell. Physiol., 233, 1321, 10.1002/jcp.26008 · DOI
- Lin, 2006, New mouse oligodendrocyte precursor (mOP) cells for studies on oligodendrocyte maturation and function, J. Neurosci. Methods, 157, 187, 10.1016/j.jneumeth.2006.04.014 · DOI
- Zhu, 2008, NG2 cells generate both oligodendrocytes and gray matter astrocytes, Development, 135, 145, 10.1242/dev.004895 · DOI
- Goldman, 2015, 142, 3983
- Kanakasabai, 2012, PPARgamma agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes, PLoS One, 7, e50500, 10.1371/journal.pone.0050500 · DOI
- Azim, 2012, Intraventricular injection of FGF-2 promotes generation of oligodendrocyte-lineage cells in the postnatal and adult forebrain, Glia, 60, 1977, 10.1002/glia.22413 · DOI
- Santos, 2012, Polymeric nanoparticles to control the differentiation of neural stem cells in the subventricular zone of the brain, ACS Nano, 6, 10463, 10.1021/nn304541h · DOI · Paper page
Cited by
Sorted by citations
MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis
Asl, E. R., Hosseini, S. E., Tahmasebi, F., Bolandi, N., & Barati, S. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01578-6 · Cited by 19
Metadata
- Authors
- Carradori, D., Labrak, Y., Miron, V. E., Saulnier, P., Eyer, J., Préat, V., & des Rieux, A.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 230
- Pages
- 119653
- ISSN
- 0142-9612
- Cited by
- 38
- References
- 5
- Language
- en
- Funders
- Fonds De La Recherche Scientifique - FNRS
- International Foundation for Research in Paraplegia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review